Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
1) Boston-Cambridge
2) SF Bay Area
3) NY/NJ
4) San Diego
5) DC/Maryland Metro
6) Greater Philadelphia
7) Seattle
8) Raleigh-Durham-Research Triangle
9) Los Angeles
10) Chicagoland
1) SF Bay Area
2) Boston-Cambridge
3) San Diego
4) DC/Maryland Metro
5) NY/NJ
6) Seattle
7) Philadelphia
8) Raleigh-Durham-Research Triangle
9) Los Angeles
10) Chicagoland
Very cool! I figured the Bay & Boston would be sparring at the top, but I'm a bit surprised by the low rankings of Philadelphia and especially the Research Triangle.
Very cool! I figured the Bay & Boston would be sparring at the top, but I'm a bit surprised by the low rankings of Philadelphia and especially the Research Triangle.
Very cool! I figured the Bay & Boston would be sparring at the top, but I'm a bit surprised by the low rankings of Philadelphia and especially the Research Triangle.
Based on the methodology, it looks like the level the venture capital and patenting is the relative weakness in the Research Triangle and Philly markets, respectively, although I know that building a more robust "commercialization pipeline" is one of the things that several institutions are working on in the Philly region.
Based on the methodology, I would imagine that the level the venture capital is the relative weakness in Philly in the Research Triangle--California, Boston and NYC (and to a lesser extent, DC) are seemingly "untouchable" in terms of the availability of VC generally.
there have been improvements. Novartis just recently heavily in a JV with CHOP and Penn but not at the levels of CA, Cambridge etc.
There is also quite a bit of innovative device spending in the Philly area not captured in this metric yet still very pioneering
the flip side is HUP and CHOP are actually some of the most advanced and pioneering research medically in the world and most is funded directly through their own coffers so does not show as VC funded - some is NIH
Overall and based on my experience in terms of advanced medical research I would say the complexes of Boston and Philly are probably the two most concentrated and advanced in the world - potentially the two best hospital cities in the US or world for that matter
Specific to biopharma research this list is likely accurate to reflect that specific aspect - in terms of US healthcare biologics represent about 9-11% of revenues today so sizable but not the most significant. I believe it is currently ~40% of research investment in aggregate for the broader healthcare space
Based on the methodology, it looks like the level the venture capital and patenting is the relative weakness in the Research Triangle and Philly markets, respectively, although I know that building a more robust "commercialization pipeline" is one of the things that several institutions are working on in the Philly region.
That would make sense. The Bay & Boston seem to be much higher when it comes to things like research, which explains their massive lab spaces (roughly 20 & 21 million for the Bay & Boston, respectively).
there have been improvements. Novartis just recently heavily in a JV with CHOP and Penn but not at the levels of CA, Cambridge etc.
There is also quite a bit of innovative device spending in the Philly area not captured in this metric yet still very pioneering
the flip side is HUP and CHOP are actually some of the most advanced and pioneering research medically in the world and most is funded directly through their own coffers so does not show as VC funded - some is NIH
Overall and based on my experience in terms of advanced medical research I would say the complexes of Boston and Philly are probably the two most concentrated and advanced in the world - potentially the two best hospital cities in the US or world for that matter
Specific to biopharma research this list is likely accurate to reflect that specific aspect - in terms of US healthcare biologics represent about 9-11% of revenues today so sizable but not the most significant. I believe it is currently ~40% of research investment in aggregate for the broader healthcare space
Agreed on your points regarding Philly and Boston, definitely two of the most impressive hospital cities on the planet.
As far as CHOP is concerned, I think they are relatively aggressive on the NIH front. CHOP secured 197 awards ($116,395,517) compared to Children's Hospital of Boston with 305 awards ($126,953,196). Of course they are both teaching hospitals, so there are further awards secured by HMS/HSPH and Penn Medicine that could have been affiliated with CHOP and CHOB.
NYC area will probably solidify their #3 spot in the coming years, since they are huge expansions currently in the works (both on healthcare and research side). There is also a new 1.5 million sq ft research hospital complex being constructed in Manhattan, that should open in 2018.
NYC area will probably solidify their #3 spot in the coming years, since they are huge expansions currently in the works (both on healthcare and research side). There is also a new 1.5 million sq ft research hospital complex being constructed in Manhattan, that should open in 2018.
I think it's fair to say that there's heavy expansion in several of these cities currently, so I don't know if there would be a significant edge in that regard.
I think it's fair to say that there's heavy expansion in several of these cities currently, so I don't know if there would be a significant edge in that regard.
Yea, the Boston area is expanding greatly at the moment. Several million square feet of lab space are under construction in East Cambridge/Kendall Square alone. There are several projects underway in Longwood Medical Area too.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.